The  	The  	 DT	O
roles  	roles  	 NNS	O
of  	of  	 IN	O
parathyroid  	parathyroid  	 JJ	B-NP
hormone  	hormone  	 NN	I-NP
in  	in  	 IN	O
bone  	bone  	 NN	O
remodeling 	remodeling 	 NN	O
:  	:  	 :	O
prospects  	prospects  	 NNS	O
for  	for  	 IN	O
novel  	novel  	 NN	O
therapeutics  	therapeutics  	 VBD	O
The  	The  	 DT	O
aim  	aim  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
review  	review  	 NN	O
is  	is  	 VBZ	O
to  	to  	 TO	O
focus  	focus  	 VB	O
on  	on  	 IN	O
the  	the  	 DT	O
roles  	roles  	 NNS	O
of  	of  	 IN	O
PTH  	PTH  	 NNP	B-NP
in  	in  	 IN	O
bone  	bone  	 NN	O
remodeling 	remodeling 	 NN	O
.  	.  	 .	O
PTH  	PTH  	 NNP	B-NP
plays  	plays  	 VBZ	O
a  	a  	 DT	O
central  	central  	 JJ	O
role  	role  	 NN	O
in  	in  	 IN	O
regulating  	regulating  	 VBG	B-NP
calcium-phosphate  	calcium-phosphate  	 JJ	I-NP
metabolism  	metabolism  	 NN	I-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
production  	production  	 NN	B-NP
increases  	increases  	 NNS	I-NP
in  	in  	 IN	O
response  	response  	 NN	O
to  	to  	 TO	O
low  	low  	 JJ	O
serum  	serum  	 JJ	B-NP
calcium  	calcium  	 NN	I-NP
levels 	levels 	 NNS	I-NP
.  	.  	 .	O
A  	A  	 DT	O
continue  	continue  	 VBP	O
hypersecretion  	hypersecretion  	 VBN	O
of  	of  	 IN	O
PTH 	PTH 	 NNP	B-NP
,  	,  	 ,	O
as  	as  	 RB	O
occurs  	occurs  	 VBZ	O
in  	in  	 IN	O
primary  	primary  	 JJ	B-NP
hyperparathyroidism 	hyperparathyroidism 	 NN	I-NP
,  	,  	 ,	O
leads  	leads  	 VBZ	O
to  	to  	 TO	O
bone  	bone  	 VB	O
resorption 	resorption 	 NNS	B-NP
.  	.  	 .	O
On  	On  	 IN	O
the  	the  	 DT	O
other  	other  	 JJ	O
hand 	hand 	 NN	O
,  	,  	 ,	O
there  	there  	 EX	O
is  	is  	 VBZ	O
clear  	clear  	 JJ	O
evidence  	evidence  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
anabolic  	anabolic  	 JJ	B-NP
properties  	properties  	 NNS	I-NP
of  	of  	 IN	I-NP
PTH.When  	PTH.When  	 CD	I-NP
administered  	administered  	 NN	O
at  	at  	 IN	O
a  	a  	 DT	O
low  	low  	 JJ	O
dose  	dose  	 NN	O
and  	and  	 CC	O
intermittently 	intermittently 	 NN	O
,  	,  	 ,	O
this  	this  	 DT	O
hormone  	hormone  	 NN	O
seems  	seems  	 VBZ	O
to  	to  	 TO	O
be  	be  	 VB	O
able  	able  	 JJ	O
to  	to  	 TO	O
exert  	exert  	 VB	O
positive  	positive  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
on  	on  	 IN	O
bone  	bone  	 NN	O
volume  	volume  	 NN	O
and  	and  	 CC	O
microarchitecture 	microarchitecture 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
PTH  	PTH  	 NNP	B-NP
are  	are  	 VBP	O
mediated  	mediated  	 VBN	O
by  	by  	 IN	O
PTH 	PTH 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
PTH-related  	PTH-related  	 JJ	I-NP
protein  	protein  	 NN	I-NP
receptor 	receptor 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
G  	G  	 NNP	B-NP
protein  	protein  	 NN	I-NP
that  	that  	 WDT	O
can  	can  	 MD	O
activate  	activate  	 VB	O
the  	the  	 DT	O
cAMP-dependent  	cAMP-dependent  	 JJ	B-NP
protein  	protein  	 NN	I-NP
kinase  	kinase  	 NNS	I-NP
( 	( 	 -LRB-	O
PK 	PK 	 NNP	B-NP
) 	) 	 -RRB-	O
A  	A  	 NNP	O
and  	and  	 CC	O
calcium-dependent  	calcium-dependent  	 NNP	B-NP
PKC 	PKC 	 NNP	I-NP
;  	;  	 :	O
the  	the  	 DT	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	I-NP
PKA  	PKA  	 NNP	I-NP
account  	account  	 NN	I-NP
for  	for  	 IN	O
most  	most  	 JJS	O
of  	of  	 IN	O
the  	the  	 DT	O
PTH  	PTH  	 NNP	B-NP
anabolic  	anabolic  	 JJ	I-NP
action 	action 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
anabolic  	anabolic  	 JJ	B-NP
actions  	actions  	 NNS	I-NP
of  	of  	 IN	I-NP
PTH  	PTH  	 NNP	I-NP
involve  	involve  	 VBP	O
direct  	direct  	 JJ	O
effects  	effects  	 NNS	O
on  	on  	 IN	O
osteoblasts  	osteoblasts  	 NN	B-NP
and  	and  	 CC	O
indirect  	indirect  	 JJ	O
effects  	effects  	 NNS	O
mediated  	mediated  	 VBN	O
by  	by  	 IN	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	I-NP
skeletal  	skeletal  	 JJ	I-NP
growth  	growth  	 NN	I-NP
factors  	factors  	 NNS	I-NP
( 	( 	 -LRB-	O
IGF-I 	IGF-I 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
growth  	growth  	 NN	B-NP
factor  	factor  	 NN	I-NP
antagonists 	antagonists 	 NNS	I-NP
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
sclerostin 	sclerostin 	 NN	B-NP
.  	.  	 .	O
PTH  	PTH  	 NNP	B-NP
enhances  	enhances  	 VBZ	O
the  	the  	 DT	O
number  	number  	 NN	O
and  	and  	 CC	O
the  	the  	 DT	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	I-NP
osteoblast  	osteoblast  	 NN	I-NP
through  	through  	 IN	O
4  	4  	 CD	O
pathways 	pathways 	 NNS	O
:  	:  	 :	O
increasing  	increasing  	 VBG	O
osteoblast  	osteoblast  	 JJ	B-NP
proliferation  	proliferation  	 NN	I-NP
and  	and  	 CC	O
differentiation 	differentiation 	 NN	B-NP
,  	,  	 ,	O
decreasing  	decreasing  	 VBG	O
osteoblast  	osteoblast  	 JJ	B-NP
apoptosis  	apoptosis  	 NN	I-NP
and  	and  	 CC	O
reducing  	reducing  	 VBG	O
the  	the  	 DT	O
negative  	negative  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	I-NP
peroxisome  	peroxisome  	 FW	I-NP
proliferator  	proliferator  	 FW	I-NP
activator  	activator  	 FW	I-NP
( 	( 	 -LRB-	O
PPAR 	PPAR 	 NNP	B-NP
) 	) 	 -RRB-	O
γ  	γ  	 JJ	O
receptor  	receptor  	 NN	B-NP
on  	on  	 IN	O
osteoblast  	osteoblast  	 JJ	B-NP
differentiation 	differentiation 	 NN	I-NP
.  	.  	 .	O
Moreover  	Moreover  	 RB	O
PTH  	PTH  	 NNP	B-NP
enhances  	enhances  	 VBZ	O
the  	the  	 DT	O
Wnt-β  	Wnt-β  	 JJ	B-NP
catenin  	catenin  	 JJ	I-NP
pathway 	pathway 	 NN	I-NP
,  	,  	 ,	O
that  	that  	 WDT	O
is  	is  	 VBZ	O
central  	central  	 JJ	O
to  	to  	 TO	O
osteogenesis  	osteogenesis  	 VB	O
and  	and  	 CC	O
bone  	bone  	 NN	O
formation 	formation 	 NN	O
,  	,  	 ,	O
inhibiting  	inhibiting  	 JJ	O
sclerostin 	sclerostin 	 NN	B-NP
.  	.  	 .	O
Finally 	Finally 	 RB	O
,  	,  	 ,	O
PTH  	PTH  	 NNP	B-NP
induces  	induces  	 VBZ	O
the  	the  	 DT	O
synthesis  	synthesis  	 NN	O
of  	of  	 IN	O
IGF-I  	IGF-I  	 JJ	B-NP
and 	and 	 CC	O
,  	,  	 ,	O
due  	due  	 JJ	O
to  	to  	 TO	O
its  	its  	 PRP$	O
prodifferentiating  	prodifferentiating  	 NN	B-NP
and  	and  	 CC	O
pro-survival  	pro-survival  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
on  	on  	 IN	O
osteoblasts 	osteoblasts 	 NN	B-NP
,  	,  	 ,	O
this  	this  	 DT	O
could  	could  	 MD	O
be  	be  	 VB	O
a  	a  	 DT	O
key  	key  	 JJ	B-NP
mediator  	mediator  	 NN	I-NP
of  	of  	 IN	I-NP
PTH  	PTH  	 NNP	I-NP
effect  	effect  	 NN	I-NP
on  	on  	 IN	O
osteoblasts 	osteoblasts 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
conclusion 	conclusion 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
intermittent  	intermittent  	 JJ	O
administration  	administration  	 NN	B-NP
of  	of  	 IN	I-NP
PTH  	PTH  	 NNP	I-NP
has  	has  	 VBZ	O
a  	a  	 DT	O
pleiotropic  	pleiotropic  	 JJ	B-NP
anabolic  	anabolic  	 JJ	I-NP
effect  	effect  	 NN	I-NP
on  	on  	 IN	O
bone 	bone 	 NN	O
;  	;  	 :	O
further  	further  	 JJ	O
studies  	studies  	 NNS	O
about  	about  	 IN	O
mechanisms  	mechanisms  	 NNS	O
of  	of  	 IN	O
action  	action  	 NN	O
of  	of  	 IN	O
PTH  	PTH  	 NNP	B-NP
could  	could  	 MD	O
be  	be  	 VB	O
a  	a  	 DT	O
starting  	starting  	 VBG	B-NP
point  	point  	 NN	I-NP
to  	to  	 TO	O
new  	new  	 JJ	O
osteoporosis  	osteoporosis  	 JJ	B-NP
treatments 	treatments 	 NNS	I-NP
.  	.  	 .	O
